The in vivo mechanisms by which the lack of Polycystin-2 leads to CFTR stimulation are an outstanding challenge in ADPKD research and may bring important biomarkers for the disease. This evidence concerns the gene PKD2 and autosomal dominant polycystic kidney disease.